NanoCarrier Co., Ltd

4571
End-of-day quote Tokyo - 03/25
428JPY
-7.36%
Prev.462.0000
Open428.0000
High428.0000
Low428.0000
Volume1 528 000
Financials
Sales 2019 460 M
EBIT 2019 -
R. net 2019 -2 222 M
Tréso. 2019 3 900 M
Rend. 2019 -
P/E ratio 2019 -
P/E ratio 2020 4 280,00
EV / Sales 2019 37,5x
EV / Sales 2020 6,23x
Capitalization 21 144 M
Company
NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar...
Sector :
Bio Therapeutic Drugs
Calendar :
2019-05-14 Earnings Release
Trading Rating : -
Investor Rating :
Latest news
01/30SanBio's crash causes margin calls, drags down Japan's start-up market
RE
2018NANOCARRIER CO., LTD. : quaterly earnings release
2016NANOCARRIER CO., LTD. : half-yearly earnings release
2016NANOCARRIER CO., LTD. : quaterly earnings release
2016NANOCARRIER CO., LTD. : annual earnings release
2014NANOCARRIER CO., LTD. : SPLIT: 100 of 1
FA
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance515535703
Spread/Res.-17%-20%-39%
Spread/Supp.1,9%50%39%
Support420285309